MS
IDXX icon

Maven Securities’s Idexx Laboratories IDXX Stock Holding History

Maven Securities’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-748
Closed -$378K – 915
2024
Q3 		$378K Sell
748
-310
-29% -$151K 0.01% 714
2024
Q2 		$515K Buy
1,058
+423
+67% +$212K 0.01% 677
2024
Q1 		$343K Buy
+635
New +$347K 0.02% 260
2023
Q4 		– Sell
-757
Closed -$331K – 1050
2023
Q3 		$331K Buy
+757
New +$377K ﹤0.01% 922
2022
Q3 		– Sell
-1,106
Closed -$388K – 1158
2022
Q2 		$388K Buy
1,106
+312
+39% +$127K 0.01% 667
2022
Q1 		$434K Buy
+794
New +$418K 0.02% 581
2020
Q3 		– Sell
-800
Closed -$296K – 677
2020
Q2 		$264K Sell
800
-69
-8% -$20K 0.02% 441
2020
Q1 		$211K Buy
+869
New +$227K 0.03% 275

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Maven Securities's IDXX Position: Q4 2024 in Review

Maven Securities sold out of Idexx Laboratories (IDXX) in Q4 2024, closing a stake of 748 shares — an estimated $378K sold.

Maven Securities first reported a position in IDXX in Q1 2020 and held it in 8 quarters. The position peaked at $515K in Q2 2024. 1,125 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

  • Maven Securities reported no remaining Idexx Laboratories position as of Q4 2024 after selling out during the quarter.
  • Maven Securities sold 748 Idexx Laboratories shares in Q4 2024, an estimated $378K.
  • Maven Securities first reported a position in Idexx Laboratories in Q1 2020 and held it in 8 quarters.
  • Maven Securities's Idexx Laboratories position peaked at $515K in Q2 2024.
  • 1,125 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on Maven Securities's 13F filing for Q4 2024, filed 14 Feb 2025.